# Which joint care choice fits the soreness I have? *Biologic Therapy Glendale | Choices for a Sore Joint* > Orthobiologics use blood or marrow from your body and are also called biologic therapy. See where exercise, cortisone, gel, and surgery may fit. A shoulder may ache before the day has properly begun, even before breakfast is finished. Reaching for a shirt can hurt, although sitting still feels comfortable. A knee or hip often complains most while carrying body weight. Where soreness starts and which motion wakes it help narrow the cause. ## Which choices come before an office procedure? Regular exercise can strengthen the muscles that carry part of a joint's load. The work takes time and needs to match your daily tasks. Weight loss may reduce strain on a knee or hip when weight matters. It won't repair worn tissue, but less force can make walking easier. Heat, cold, medicine, and lighter work may calm a flare. Your doctor can check which medicine is safe with your other pills. ## What are the choices that use a needle? Cortisone is often chosen for quicker relief that may not last. Gel uses a made form of part of normal joint fluid. Orthobiologics are office procedures that prepare your blood or marrow. Biologic therapy is another broad name for this group of choices. Here, PRP stands for platelet-rich plasma. The clinic makes it by spinning blood taken from you. ## When does surgery enter the talk? Severe wear can bring soreness at rest, poor motion, and trouble with short walks. When that happens, surgery may deserve a direct talk with your doctor. Blood- or marrow-based procedures haven't been proved to replace needed joint surgery. Waiting too long can leave you sore without protecting the joint. If surgery isn't advised, ask what each choice may change in daily life. Easier walking, better sleep, and improved quality of life are clear goals. ## Sources 1. A Bayesian network meta-analysis of 48 Level I-II randomized trials (9,338 knees) with a minimum 6-month follow-up ranked the four commonest intra-articular injections. HA and PRP both significantly improved pain versus placebo; HA, PRP and BMAC all significantly improved function versus placebo. SUCRA rankings were PRP 91.54, BMAC 76.46, HA 53.12, corticosteroid 15.18 and placebo 13.70 - corticosteroid ranked barely above placebo at six months and beyond. Jawanda H, et al. — [Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/38331363/). *Arthroscopy*, 2024. DOI: 10.1016/j.arthro.2024.01.037. 2. A network meta-analysis restricted to LARGE randomized trials (at least 100 patients per group; 57 RCTs, 22,795 participants, 18 intra-articular interventions) found treatment effects were consistently larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials. In the main analysis excluding high-risk trials, triamcinolone had the highest probability of exceeding the minimal important difference at weeks 2 and 6; hyaluronic acid had no effect on pain (SMD -0.04, 95% CrI -0.19 to 0.11, 11 trials) but higher odds of dropouts due to adverse events (OR 2.01) and of serious adverse events (OR 1.86). The effects of 16 of the 18 interventions were smaller than the MID and most were consistent with placebo effects. Pereira TV, et al. — [Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/39265924/). *Osteoarthritis and Cartilage*, 2025. DOI: 10.1016/j.joca.2024.08.014. 3. A meta-analysis of 18 Level I trials (811 PRP vs 797 HA patients, mean follow-up 11.1 months) found mean WOMAC total improvement of 44.7% with PRP versus 12.6% with HA (P<.01). Six of 11 VAS-based studies and 3 of 6 IKDC-based studies favoured PRP significantly. In the subanalysis, leukocyte-POOR PRP was associated with significantly better subjective IKDC scores than leukocyte-rich PRP. Belk JW, et al. — [Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.](https://pubmed.ncbi.nlm.nih.gov/32302218/). *American Journal of Sports Medicine*, 2021. DOI: 10.1177/0363546520909397. 4. A meta-analysis of 27 Level I studies (1,042 PRP, 226 BMAC, 1,128 HA patients) found significantly better post-injection WOMAC, VAS and subjective IKDC scores for BOTH PRP and BMAC compared with hyaluronic acid - and NO significant difference between PRP and BMAC on any outcome score. This is the clearest published statement that the two most-marketed orthobiologics perform the same as each other in the knee. Belk JW, et al. — [Patients With Knee Osteoarthritis Who Receive Platelet-Rich Plasma or Bone Marrow Aspirate Concentrate Injections Have Better Outcomes Than Patients Who Receive Hyaluronic Acid: Systematic Review and Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/36913992/). *Arthroscopy*, 2023. DOI: 10.1016/j.arthro.2023.03.001. 5. A network meta-analysis of 43 trials (5,554 patients) reached the OPPOSITE ranking to the more recent orthobiologic-favourable reviews: steroids ranked most likely to be effective for pain and function, with adipose MSC and multiple PRP ranked LEAST likely; single PRP, multiple PRP and adipose MSC did not produce a relevant reduction in pain or improvement in function versus placebo. The authors noted treatment-effect differences were small and potentially not clinically meaningful either way. Han SB, et al. — [Intra-Articular Injections of Hyaluronic Acid or Steroids Associated With Better Outcomes Than Platelet-Rich Plasma, Adipose Mesenchymal Stromal Cells, or Placebo in Knee Osteoarthritis: A Network Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/32305424/). *Arthroscopy*, 2021. DOI: 10.1016/j.arthro.2020.03.041. 6. A Bayesian network meta-analysis restricted to trials with at least one year of follow-up (37 RCTs, 5,089 patients) ranked combined PRP+HA first for both pain relief and function at one year, ahead of PRP alone, then HA+corticosteroid, then HA alone, then placebo, with corticosteroid alone ranked LAST - below placebo. Gupta N, et al. — [Long-term effectiveness of intra-articular injectables in patients with knee osteoarthritis: a systematic review and Bayesian network meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/40025522/). *Journal of Orthopaedic Surgery and Research*, 2025. DOI: 10.1186/s13018-025-05574-w. 7. A randomized trial allocated 175 patients with KL II-IV knee OA to BMAC (n=111), PRP (n=34) or hyaluronic acid (n=30) and followed them for 12 months. All three produced significant improvement from baseline in WOMAC, KOOS and IKDC with no serious side effects; BMAC showed significantly better clinical improvement than PRP and HA on most scores, and PRP scored higher than HA without reaching statistical significance. Note the unequal, non-blinded design - this is the strongest direct BMAC-versus-PRP randomized comparison available, and it is not a strong design. Dulic O, et al. — [Bone Marrow Aspirate Concentrate versus Platelet Rich Plasma or Hyaluronic Acid for the Treatment of Knee Osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/34833411/). *Medicina (Kaunas)*, 2021. DOI: 10.3390/medicina57111193. 8. A 2026 network meta-analysis of 21 RCTs (2,254 patients) found both leukocyte-rich and leukocyte-poor PRP significantly superior to placebo and to hyaluronic acid for function at 6-12 months (MD vs placebo -13.20 and -10.54 respectively). LP-PRP ranked highest (P-score 0.96) but the DIRECT comparison between the two formulations showed no statistically significant difference, and the authors concluded there is insufficient evidence to recommend one PRP formulation over the other. Xu B, et al. — [Leukocyte-rich versus leukocyte-poor platelet-rich plasma and hyaluronic acid for knee osteoarthritis: a systematic review and network meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41629990/). *Journal of Orthopaedic Surgery and Research*, 2026. DOI: 10.1186/s13018-026-06689-4. 9. FDA states verbatim of stem cell products, stromal vascular fraction (adipose-derived cells), umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products: 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells derived from umbilical cord blood, approved only for disorders of blood production, and there are currently NO FDA-approved exosome products. U.S. Food and Drug Administration — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA (Center for Biologics Evaluation and Research)*, 2020. 10. FDA's patient and consumer notice on regenerative medicine states that it has received reports of BLINDNESS, TUMOUR FORMATION, neurological events, bacterial infections including life-threatening blood infections, unwanted immune reactions, and cells migrating and forming unintended tissue, following the use of unapproved regenerative medicine products - a list that explicitly includes stromal vascular fraction, amniotic fluid, Wharton's jelly, ortho-biologics and exosomes. It also warns that a product's presence on clinicaltrials.gov, or a firm's registration with FDA, does NOT mean the product is legally marketed. U.S. Food and Drug Administration — [Important Patient and Consumer Information About Regenerative Medicine Therapies](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies). *FDA (Center for Biologics Evaluation and Research)*, 2021. 11. A meta-analysis of the PLACEBO arms of 73 double-blind trials (5,895 patients) quantified what a saline knee injection alone achieves: statistically and clinically significant improvement in pain, function and quality of life at 1, 3 and 6 months, with responder rates exceeding 50% at all three time points, peaking around 4-8 months and declining by 12 months. Placebo response was stronger in trials with more female participants and in more recently published trials. Previtali D, et al. — [Placebo response to intra-articular injections in knee osteoarthritis: magnitude, evolution over time, and influencing factors. A systematic review and meta-analysis with meta-regression.](https://pubmed.ncbi.nlm.nih.gov/41031623/). *EFORT Open Reviews*, 2025. DOI: 10.1530/EOR-2025-0022. ## What if the soreness doesn't settle? If soreness keeps limiting your day, QC Kinetix offers a visit with medical providers, the clinic staff who examine joints and discuss care before you make a treatment choice together. They provide regenerative treatments, meaning procedures that start with blood or marrow collected for your care. These biologic therapies aim to ease soreness and improve quality of life, although results differ. Your first consultation has no charge, and the clinician begins with your joint history. PRP stands for platelet-rich plasma and comes from blood drawn from you, then spun. Platelets are small blood parts that help clotting and start repair signals. Concentrated PRP keeps more of those platelets, but the name alone doesn't prove more relief. Joint preservation means trying non-surgical care before joint replacement, including knee or hip surgery alternatives when they fit. Book a free consultation: --- Plain help for a joint that stays sore. Biologic therapy Glendale residents can understand: blood or marrow is collected and prepared for care, with plain guidance on soreness and daily movement. Plain help with joint soreness, home care, warning signs, and questions to bring to an exam. This site is operated by the owners of QC Kinetix clinics across the Phoenix area, including the Peoria and Banner Estrella locations described here; the business benefits when a reader books a consultation. Copyright 2026 Glendale Biologic Status. General education about orthopedic treatment evidence, not medical advice for an individual joint.